REDMOND, Wash.--(BUSINESS WIRE)--Vesiflo, Inc., today announced that its Direct De Novo Petition for the inFlowâ„¢ Urinary Prosthesis has been granted by the U.S. Food and Drug Administration (FDA), ...
ENLARGEMENT of the prostate is so preponderantly the major cause of urinary retention and its surgical treatment has been so generally successful that it may mask other disturbances of bladder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results